XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.2
UNAUDITED CONDENSED INTERIM CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Apr. 30, 2019
Jul. 31, 2018
Current Assets:    
Cash and cash equivalents $ 1,407,837 $ 1,046,365
Accounts receivable, net 1,803,192 33,555
Inventory, net 250,021 12,075
Other current assets 218,819 96,251
Total Current Assets 3,679,869 1,188,246
Property and equipment 556,276 31,536
Notes receivable - noncurrent 1,426,164
Call option 2,168,211
Goodwill and Intangible assets 48,323,164 3,187,757
Patents, net 21,362 23,280
Other assets, net 29,421 7,824
TOTAL ASSETS 54,036,256 6,606,854
Current Liabilities:    
Accounts payable and accrued expenses 19,863,047 11,044,774
Notes payable, current 7,029,049 320,000
Loans from related parties 13,200 13,864,241
Other current liabilities 4,702
Deferred tax liability 1,929,955
Total Current Liabilities 28,839,953 25,229,015
Other noncurrent liabilities 2,233
Derivative liability - convertible notes 3,937,513
Derivative liability - warrants 257,478
Derivative liability - downside protection 6,994,450
Common stock payable 201,294
Warrants to be issued 24,962,507
Total Liabilities 40,232,921 50,191,522
Redeemable non-controlling interest 4,073,898
Stockholders' Equity (Deficiency)    
Common stock, $.001 par value; authorized 750,000,000 shares at April 30, 2019 and July 31, 2018; 60,362,163 and 22,430,121 issued and outstanding at April 30, 2019 and July 31, 2018, respectively 60,362 22,430
Common stock payable 2,168,951
Additional paid-in capital 400,844,512 368,388,265
Accumulated deficit (413,941,958) (409,386,468)
Accumulated other comprehensive income 807,764 798,422
Non-controlling interest 21,958,757 (5,576,272)
Total Stockholders' Equity (Deficiency) 13,803,335 (43,584,668)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY) 54,036,256 6,606,854
Series H Convertible Preferred Stock    
Stockholders' Equity (Deficiency)    
Convertible Preferred Stock 3
Regentys Series A Redeemable Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficiency)    
Convertible Preferred Stock  
Olaregen Series A Preferred Stock [Member]    
Stockholders' Equity (Deficiency)    
Convertible Preferred Stock  
Series I Convertible Preferred Stock    
Stockholders' Equity (Deficiency)    
Convertible Preferred Stock $ 1